Detection of HTLV-I proviral DNA by fluorescence in situ hybridization. 1997

Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu

UI MeSH Term Description Entries
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015458 Leukemia, T-Cell A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood. Leukemia, Lymphocytic, T-Cell,Lymphocytic Leukemia, T-Cell,T-Cell Leukemia,T-Lymphocytic Leukemia,Leukemia, Lymphocytic, T Cell,T Lymphocytic Leukemia,Leukemia, T Cell,Leukemia, T Lymphocytic,Leukemia, T-Cell Lymphocytic,Leukemia, T-Lymphocytic,Leukemias, T Lymphocytic,Leukemias, T-Cell,Leukemias, T-Cell Lymphocytic,Leukemias, T-Lymphocytic,Lymphocytic Leukemia, T,Lymphocytic Leukemia, T Cell,Lymphocytic Leukemias, T,Lymphocytic Leukemias, T-Cell,T Cell Leukemia,T Lymphocytic Leukemias,T-Cell Leukemias,T-Cell Lymphocytic Leukemia,T-Cell Lymphocytic Leukemias,T-Lymphocytic Leukemias
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017404 In Situ Hybridization, Fluorescence A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei. FISH Technique,Fluorescent in Situ Hybridization,Hybridization in Situ, Fluorescence,FISH Technic,Hybridization in Situ, Fluorescent,In Situ Hybridization, Fluorescent,FISH Technics,FISH Techniques,Technic, FISH,Technics, FISH,Technique, FISH,Techniques, FISH

Related Publications

Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
January 2001, Dermatology (Basel, Switzerland),
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
February 1992, The American journal of medicine,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
May 1994, Nihon Kyobu Shikkan Gakkai zasshi,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
January 2012, Methods in molecular biology (Clifton, N.J.),
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
September 1989, Journal of clinical immunology,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
August 1990, BioTechniques,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
January 1991, Environmental and molecular mutagenesis,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
January 2024, Nature nanotechnology,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
July 1992, Nihon rinsho. Japanese journal of clinical medicine,
Y Uemura, and T Kubota, and T Miyagi, and J Imamura, and I Kubonishi, and H Taguchi, and I Miyoshi, and K Shimizu
January 2003, Blood cells, molecules & diseases,
Copied contents to your clipboard!